Search research articles
Contact Us
Filters
Showing results (151-160 of 165) with videos related to
Page
of 17
Sort By:
Haematologica
|
April 4, 2020
Clinical practice recommendation on hematopoietic stem cell transplantation for acute myeloid leukemia patients with <i>FLT3</i>-internal tandem duplication: a position statement from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
Ali Bazarbachi, Gesine Bug, Frederic Baron, et al.
The Lancet. Haematology
|
February 26, 2021
Development and validation of a disease risk stratification system for patients with haematological malignancies: a retrospective cohort study of the European Society for Blood and Marrow Transplantation registry
Roni Shouval, Joshua A Fein, Myriam Labopin, et al.
Bone Marrow Transplantation
|
January 31, 2018
Effective treatment of steroid and therapy-refractory acute graft-versus-host disease with a novel mesenchymal stromal cell product (MSC-FFM)
Peter Bader, Zyrafete Kuçi, Shahrzad Bakhtiar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 4, 2019
Valproate and Retinoic Acid in Combination With Decitabine in Elderly Nonfit Patients With Acute Myeloid Leukemia: Results of a Multicenter, Randomized, 2 × 2, Phase II Trial
Michael Lübbert, Olga Grishina, Claudia Schmoor, et al.
Bone Marrow Transplantation
|
January 31, 2020
Redefining and measuring transplant conditioning intensity in current era: a study in acute myeloid leukemia patients
Alexandros Spyridonidis, Myriam Labopin, Bipin N Savani, et al.
Bone Marrow Transplantation
|
March 8, 2020
Correction: Redefining and measuring transplant conditioning intensity in current era: a study in acute myeloid leukemia patients
Alexandros Spyridonidis, Myriam Labopin, Bipin N Savani, et al.
Journal of Hematology & Oncology
|
July 22, 2023
Treatment of adult ALL patients with third-generation CD19-directed CAR T cells: results of a pivotal trial
Maria-Luisa Schubert, Anita Schmitt, Angela Hückelhoven-Krauss, et al.
European Journal of Haematology
|
October 14, 2024
Impact of TP53 Mutation Status in Elderly AML Patients When Adding All-Trans Retinoic Acid or Valproic Acid to Decitabine
Helena Bresser, Claudia Schmoor, Olga Grishina, et al.
Blood
|
December 8, 2025
Azacitidine to treat measurable residual disease in patients with MDS/AML: final long-term results of the RELAZA2 trial
Anne Sophie Platzbecker, Julia Annabell Georgi, Jan Moritz Middeke, et al.
Cells
|
December 11, 2019
Children and Adults with Refractory Acute Graft-versus-Host Disease Respond to Treatment with the Mesenchymal Stromal Cell Preparation "MSC-FFM"-Outcome Report of 92 Patients
Halvard Bonig, Zyrafete Kuçi, Selim Kuçi, et al.
Page
of 17
Search research articles
Search
Showing results (151-160 of 165) with videos related to
Sort By:
Page
of 17
Haematologica
|
April 4, 2020
Clinical practice recommendation on hematopoietic stem cell transplantation for acute myeloid leukemia patients with <i>FLT3</i>-internal tandem duplication: a position statement from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
Ali Bazarbachi, Gesine Bug, Frederic Baron, et al.
The Lancet. Haematology
|
February 26, 2021
Development and validation of a disease risk stratification system for patients with haematological malignancies: a retrospective cohort study of the European Society for Blood and Marrow Transplantation registry
Roni Shouval, Joshua A Fein, Myriam Labopin, et al.
Bone Marrow Transplantation
|
January 31, 2018
Effective treatment of steroid and therapy-refractory acute graft-versus-host disease with a novel mesenchymal stromal cell product (MSC-FFM)
Peter Bader, Zyrafete Kuçi, Shahrzad Bakhtiar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 4, 2019
Valproate and Retinoic Acid in Combination With Decitabine in Elderly Nonfit Patients With Acute Myeloid Leukemia: Results of a Multicenter, Randomized, 2 × 2, Phase II Trial
Michael Lübbert, Olga Grishina, Claudia Schmoor, et al.
Bone Marrow Transplantation
|
January 31, 2020
Redefining and measuring transplant conditioning intensity in current era: a study in acute myeloid leukemia patients
Alexandros Spyridonidis, Myriam Labopin, Bipin N Savani, et al.
Bone Marrow Transplantation
|
March 8, 2020
Correction: Redefining and measuring transplant conditioning intensity in current era: a study in acute myeloid leukemia patients
Alexandros Spyridonidis, Myriam Labopin, Bipin N Savani, et al.
Journal of Hematology & Oncology
|
July 22, 2023
Treatment of adult ALL patients with third-generation CD19-directed CAR T cells: results of a pivotal trial
Maria-Luisa Schubert, Anita Schmitt, Angela Hückelhoven-Krauss, et al.
European Journal of Haematology
|
October 14, 2024
Impact of TP53 Mutation Status in Elderly AML Patients When Adding All-Trans Retinoic Acid or Valproic Acid to Decitabine
Helena Bresser, Claudia Schmoor, Olga Grishina, et al.
Blood
|
December 8, 2025
Azacitidine to treat measurable residual disease in patients with MDS/AML: final long-term results of the RELAZA2 trial
Anne Sophie Platzbecker, Julia Annabell Georgi, Jan Moritz Middeke, et al.
Cells
|
December 11, 2019
Children and Adults with Refractory Acute Graft-versus-Host Disease Respond to Treatment with the Mesenchymal Stromal Cell Preparation "MSC-FFM"-Outcome Report of 92 Patients
Halvard Bonig, Zyrafete Kuçi, Selim Kuçi, et al.
Page
of 17